228 related articles for article (PubMed ID: 36676131)
1. Review: The Key Factors to Melanomagenesis.
Jitian Mihulecea CR; Rotaru M
Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676131
[TBL] [Abstract][Full Text] [Related]
2. Black and Brown Oro-facial Mucocutaneous Neoplasms.
Natarajan E
Head Neck Pathol; 2019 Mar; 13(1):56-70. PubMed ID: 30693458
[TBL] [Abstract][Full Text] [Related]
3. Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances.
Strashilov S; Yordanov A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203771
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
[TBL] [Abstract][Full Text] [Related]
5. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma and nevocellular nevi. Histogenesis and relationships. Fluorescence-microscopic and catamnestic photographic studies.
Paul E
Norm Pathol Anat (Stuttg); 1984; 48():1-112. PubMed ID: 6701085
[TBL] [Abstract][Full Text] [Related]
7. How, and from which cell sources, do nevi really develop?
Grichnik JM; Ross AL; Schneider SL; Sanchez MI; Eller MS; Hatzistergos KE
Exp Dermatol; 2014 May; 23(5):310-3. PubMed ID: 24588745
[TBL] [Abstract][Full Text] [Related]
8. [Intraepidermal distribution patterns of melanocytes in the melanocytic lesions on the sole: proposed criteria for histopathologic diagnosis of plantar malignant melanoma in situ].
Saida T; Yoshida N
Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):553-60. PubMed ID: 2585770
[TBL] [Abstract][Full Text] [Related]
9. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the Hippo tumor suppressor pathway promotes melanoma.
Vittoria MA; Kingston N; Kotynkova K; Xia E; Hong R; Huang L; McDonald S; Tilston-Lunel A; Darp R; Campbell JD; Lang D; Xu X; Ceol CJ; Varelas X; Ganem NJ
Nat Commun; 2022 Jun; 13(1):3732. PubMed ID: 35768444
[TBL] [Abstract][Full Text] [Related]
11. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD44 variant isoforms in malignant melanoma.
Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
[TBL] [Abstract][Full Text] [Related]
13. Nuclear parameters in the superficial and deep portion of melanocytic lesions--a morphometrical investigation.
Smolle J; Soyer HP; Juettner FM; Hoedl S; Kerl H
Pathol Res Pract; 1988 Jun; 183(3):266-70. PubMed ID: 3420029
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous tumors of children.
NEWMAN BA
Calif Med; 1957 Jan; 86(1):1-7. PubMed ID: 13383381
[TBL] [Abstract][Full Text] [Related]
15. Acral melanocytic neoplasms: a histologic analysis of 158 lesions.
Boyd AS; Rapini RP
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):740-5. PubMed ID: 7929919
[TBL] [Abstract][Full Text] [Related]
16. Topography of Protein Kinase C βII in Benign and Malignant Melanocytic Lesions.
Krasagakis K; Tsentelierou E; Chlouverakis G; Stathopoulos EN
Int J Surg Pathol; 2017 Sep; 25(6):497-501. PubMed ID: 28436290
[TBL] [Abstract][Full Text] [Related]
17. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
Sexton M; Sexton CW
Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
[TBL] [Abstract][Full Text] [Related]
18. Histogenesis of cutaneous malignant melanoma: The vast majority do not develop from melanocytic nevus but arise de novo as melanoma in situ.
Saida T
J Dermatol; 2019 Feb; 46(2):80-94. PubMed ID: 30632197
[TBL] [Abstract][Full Text] [Related]
19. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
[TBL] [Abstract][Full Text] [Related]
20. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
Sagebiel RW
J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
